Search Results 1051-1060 of 18130 for monoclonal antibody

  1. Infectious Diseases! Clinical Trials - Mayo Clinic Research

    ... antibody detectable targets on cancer cells (cancer vaccines or antibody ... Monoclonal Antibodies To Treat Hospitalized Patients With COVID-19 Rochester, MN.

  2. A Study to Identify Pathogens and Antibodies (Metagenomic Next-Generation Sequencing) in a Patient with Meningoencephalitis - Mayo Clinic

    The purpose of this study is to identify known and unknown pathogens and antibodies that can cause severe disease in hospitalized patients. Participation ...

  3. A Trial Of ZL-1201 In Subjects With Advanced Cancer - Mayo Clinic

    About this study. First in Human, Phase I Trial of Anti-CD47 Antibody ZL-1201 in Subjects with Advanced Cancer. Participation eligibility.

  4. Publications - David Dingli, M.D., Ph.D. - Mayo Clinic

    Outcomes of triple class (proteasome inhibitor, IMiDs and monoclonal antibody) refractory patients with multiple myeloma. Leukemia 2022 Mar; 36 (3):873-876 ...

  5. A Study To Evaluate RVT-1401 For The Treatment Of Patients With Active, Moderate-to-severe Graves' Ophthalmopathy - Mayo Clinic

    Use of rituximab, tocilizumab, or any monoclonal antibody/Fc-fusion biologic for immunomodulation within the past 9 months prior to Baseline. Use of ...

  6. VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer - Mayo Clinic

    A history of hypersensitivity to other humanized monoclonal antibodies. Significant cardiovascular disease (New York Heart Association Class II or greater) ...

  7. A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody In Solid Tumors - Mayo Clinic

    A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody In Solid Tumors · Share · Facebook · Twitter.

  8. ASPEN-09: A Study Of Evorpacept In Combination With Anti-cancer Therapies In Advanced / Metastatic Malignancies - Mayo Clinic

    Immune therapy or other biologic therapy (e.g., monoclonal antibodies, antibody-drug conjugates) for the treatment of cancer for: 28 days or 5 half-lives ( ...

  9. Study identifies clinical phenotype, visual outcomes of MOG-IgG antibody optic neuritis

    Study identifies clinical phenotype, visual outcomes of MOG-IgG antibody optic neuritis ... Two novel glial autoantibodies discovered in the past 15 years enable ...

  10. Study Of Relacorilant In Combination With Pembrolizumab For Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production - Mayo Clinic

    History of severe hypersensitivity to another monoclonal antibody. Other concurrent cancer or a history of another invasive malignancy within the last 3 ...